A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
Article Details
- CitationCopy to clipboard
Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
Nature. 1996 Jul 25;382(6589):319-24.
- PubMed ID
- 8684459 [ View in PubMed]
- Abstract
The adenoviral oncoprotein E1A induces progression through the cell cycle by binding to the products of the p300/CBP and retinoblastoma gene families. A new cellular p300/CBP-associated factor (P/CAF) having intrinsic histone acetylase activity has been identified that competes with E1A. Exogenous expression of P/CAF in HeLa cells inhibits cell-cycle progression and counteracts the mitogenic activity of E1A. E1A disturbs the normal cellular interaction between p300/CBP and its associated histone acetylase.